Oral 9 – Combining Surgical Pyloroplasty and Gastric Electrical Stimulation in Gastroparetic Patients Is Superior to Pyloroplasty Alone: A Randomized Double Blind Placebo Control Trial
Monday, October 24, 2022 | 10:06 AM – 10:18 AM ET | Location: Hall C2
Author Insight from Irene Sarosiek, MD, Texas Tech University Health Sciences Center
What’s new here and important for clinicians?
In a randomized double blind study, 30 patients with drug-refractory gastroparesis underwent Heineken-Mikulicz pyloroplasty with the implantation of a gastric electrical stimulation (GES) system. Patients were randomized into 2 groups: In 15 subjects, GES was kept OFF (GES-OFF group) and in 15 others it was turned ON after surgery (GES-ON group). After 3 months of double blind placebo control phase of the trial, GES was turned ON in GES-OFF group, while GES system continues to be on in GES-ON group. Patients were followed up for additional 3 months. This study demonstrated that GES ON plus pyloroplasty was significantly more effective in controlling gastroparesis symptoms and particularly vomiting when compared with pyloroplasty alone (GES-OFF group). In both GES-ON and GES-OFF groups, gastric emptying was accelerated suggesting a role for pyloroplasty in these patients. Hospitalization was significantly reduced in GES-ON vs. GES-OFF group. Implantation of GES system with pyloroplasty could be accomplished simultaneously with no major technical or surgical complications.
What do patients need to know?
The most important message for patients is the fact that, after failing all approved medication (this list is very short) there is a hope to control their severe symptoms of gastroparesis with utilization of the implantable system and pyloroplasty.
Author Contact
Irene Sarosiek, MD, Texas Tech University Health Sciences Center
irene.sarosiek [at] ttuhsc.edu
Media Interview Requests
To arrange an interview with any ACG experts or abstract authors, please contact Becky Abel of ACG via email at mediaonly [at] gi.org or by phone at 301-263-9000.